Subtype
Stage
Gender (f/m)
Age mean (stnd dev)
Total
IA
IB
IIA
IIB
IIIA
IIIIB
IV
n.a.
SCLC
9
11
8
11
1
7
13
19/41
62 (9)
60
LCNEC
9
6
4
3
6
2
2
0
10/22
63 (9)
32
AC
15
5
12
1
7
2
28/14
52 (15)
42
TC
56
2
35/23
48 (16)
58
Table 1:
Clinical data: staging is reported according to the AJCC 7th edition. n.a.: not available; small-cell lung cancer (SCLC), large-cell neuroendocrine tumors of the lung (LCNEC), atypical carcinoids (AC), typical carcinoids (TC).
